FOCUS ON ONDANSETRON - AN ANTIEMETIC WITH A UNIQUE MECHANISM OF ACTION

被引:0
|
作者
GANNON, R
机构
来源
HOSPITAL FORMULARY | 1990年 / 25卷 / 12期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1209 / &
相关论文
共 50 条
  • [31] ONDANSETRON - A COST-EFFECTIVE ADVANCE IN ANTIEMETIC THERAPY
    COX, F
    HIRSCH, J
    ONCOLOGY, 1993, 50 (03) : 186 - 190
  • [32] ONDANSETRON - A NEW ANTIEMETIC FOR PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY
    EINHORN, LH
    NAGY, C
    WERNER, K
    FINN, AL
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) : 731 - 735
  • [33] Contextual conditioning with an illness US is attenuated by the antiemetic ondansetron
    Symonds, M
    Hall, G
    PSYCHOBIOLOGY, 2000, 28 (03) : 360 - 366
  • [34] Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone
    Gerrit Frommeyer
    Christina Fischer
    Christian Ellermann
    Philipp S. Lange
    Dirk G. Dechering
    Simon Kochhäuser
    Michael Fehr
    Lars Eckardt
    Cardiovascular Toxicology, 2017, 17 : 451 - 457
  • [35] Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone
    Frommeyer, Gerrit
    Fischer, Christina
    Ellermann, Christian
    Lange, Philipp S.
    Dechering, Dirk G.
    Kochhaeuser, Simon
    Fehr, Michael
    Eckardt, Lars
    CARDIOVASCULAR TOXICOLOGY, 2017, 17 (04) : 451 - 457
  • [36] Antiemetic prophylaxis with promethazine or ondansetron in major gynaecological surgery
    Olatosi, O. J.
    Kushimo, O.
    Okeke, C.
    Oriyomi, O.
    Ajayi, G. O.
    SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA, 2008, 14 (06) : 39 - 42
  • [37] Ondansetron antiemetic prophylaxis in patients undergoing fractionated radiotherapy
    Franzen, L
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 158 - 158
  • [38] CORRELATION OF ANTIEMETIC EFFICACY AND PLASMA-LEVELS OF ONDANSETRON
    GRUNBERG, SM
    GROSHEN, S
    ROBINSON, DC
    STEVENSON, LL
    SANDERSON, PE
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (08) : 879 - 882
  • [39] AN OPEN STUDY OF ONDANSETRON (O) AS ANTIEMETIC IN PATIENTS FAILING USUAL ANTIEMETIC THERAPY FOR CYTOTOXIC CHEMOTHERAPY
    ALLAN, SG
    FORGESON, GV
    HUMM, G
    LANGLEY, G
    NEW ZEALAND MEDICAL JOURNAL, 1991, 104 (913) : 234 - 234
  • [40] Unique features of trabectedin mechanism of action
    Larsen, Annette K.
    Galmarini, Carlos M.
    D'Incalci, Maurizio
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) : 663 - 671